Tata 1mg FY22 revenue up 66% to Rs 222 cr; net loss narrows to Rs

Tata group-owned online pharmacy 1mg's revenue from operations rose 65.7 per cent to Rs 222.10 crore in FY22, while its net loss narrowed to Rs 146.30 crore, according to data sourced by business intelligence platform Tofler.
Tata group-owned online pharmacy 1mg's revenue from operations rose 65.7 per cent to Rs 222.10 crore in FY22, while its net loss narrowed to Rs 146.30 crore, according to data sourced by business intelligence platform Tofler.

Tata group's e-pharmacy 1mg pares losses to ₹146 cr in FY22 - The Hindu BusinessLine

Tata Digital's 1mg scales 2X in FY22, losses cross Rs 525 Cr

Q4fy23 Conference Call Ktas 13th June, 2023, PDF, Demand

Tata 1mg's Net Loss Soars 2.3X To INR 1,259 Cr In FY23

Tata 1MG's growth prescription

Tata 1MG's growth prescription

Tcs 0824, PDF, Bloomberg L.P.

Tata 1mg overtakes PharmEasy as leaders in India's e-pharmacy market

Tata Steel Long Products reports Rs 184 crores loss in Q4, tata steel

Q4fy23 Conference Call Ktas 13th June, 2023, PDF, Demand

Net Loss, Latest & Breaking News on Net Loss

Licious' revenue grows 64% in FY22 while losses past Rs 855 Cr

Tata 1MG FY22 Loss Widens To INR 526 Cr Despite Over 2X Jump In Operating Revenue

Tata Digital: 1mg turns unicorn after latest funding led by Tata Digital - The Economic Times

Tata 1mg Labs and dentsu X launch campaign for accurate diagnostics – adobo Magazine

Compare Pharmacy Prices in India: Tata 1mg vs Pharmeasy

Glimepiride 1mg Tablet In All India at Rs 414/box in Ambala

Tata 1mg partners with Vitonnix UK to introduce Sublingual Vitamin